Woodline Partners’s Elanco Animal Health ELAN Stock Holding History

Woodline Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-462,390	Closed	-$10.5M	–	1070
2025 Q4	$10.5M	Sell	462,390 -3,207,113	-87%	-$69.8M	0.04%	453
2025 Q3	$73.9M	Buy	3,669,503 +480,318	+15%	+$8.05M	0.35%	60
2025 Q2	$45.5M	Buy	+3,189,185	New	+$37.3M	0.24%	114
2024 Q3	–	Sell	-594,979	Closed	-$8.59M	–	629
2024 Q2	$8.59M	Buy	+594,979	New	+$9.51M	0.08%	270
2024 Q1	–	Sell	-1,227,165	Closed	-$18.3M	–	564
2023 Q4	$18.3M	Sell	1,227,165 -2,612,962	-68%	-$29.6M	0.2%	152
2023 Q3	$43.2M	Buy	3,840,127 +3,130,273	+441%	+$36.4M	0.51%	42
2023 Q2	$7.14M	Buy	+709,854	New	+$6.59M	0.08%	249
2021 Q3	–	Sell	-136,322	Closed	-$4.73M	–	702
2021 Q2	$4.73M	Buy	+136,322	New	+$4.5M	0.09%	228
2021 Q1	–	Sell	-383,325	Closed	-$11.8M	–	441
2020 Q4	$11.8M	Buy	+383,325	New	+$11.7M	0.31%	97

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Woodline Partners's ELAN Position: Q1 2026 in Review

Woodline Partners sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 462,390 shares — an estimated $10.5M sold.

Woodline Partners first reported a position in ELAN in Q4 2020 and held it in 9 quarters. The position peaked at $73.9M in Q3 2025. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Woodline Partners reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
Woodline Partners sold 462,390 Elanco Animal Health shares in Q1 2026, an estimated $10.5M.
Woodline Partners first reported a position in Elanco Animal Health in Q4 2020 and held it in 9 quarters.
Woodline Partners's Elanco Animal Health position peaked at $73.9M in Q3 2025.
515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.